Related Experiment Video
Updated: Jun 12, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Differential Wnt/β-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes
Thomas A Kluiver1, Anna Nordin2,3,4, Yuyan Lu1,5
1Princess Máxima Center for Pediatric Oncology, Utrecht 3584 CH, The Netherlands.
Abstract:
The mechanisms by which Wnt/β-catenin signaling regulates gene expression in a tissue- and context-specific manner remain poorly understood, limiting our ability to target the aberrant cell growth typical of many Wnt-driven cancers. Here, we focus on malignant liver tumors driven by activating CTNNB1 (β-catenin) mutations that nevertheless display distinct phenotypic states and Wnt outputs. By profiling patient-derived organoids via single-cell transcriptomics and chromatin dynamics, we identify subtype-specific transcriptional and epigenetic profiles. Using CUT&RUN, we show that β-catenin engages distinct genomic regions, dictated by differential association with TCF/LEF family transcription factors. Specifically, we define a sequence-specific regulatory element engaged by β-catenin only upon interaction with TCF7L2, revealing that partner choice, independent of CTNNB1 mutational status, ultimately determines cell fate. Our findings, validated across multiple tumor models and patient tissues, offer a framework for understanding how differential β-catenin-TCF/LEF interaction orchestrates context-specific Wnt signaling outcomes.
Insights
Wnt/β-catenin signaling in liver cancer is context-specific. β-catenin partners with different TCF/LEF factors, like TCF7L2, to control gene expression and cell fate, regardless of mutation status.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Wnt/β-catenin signaling is crucial for development and implicated in various cancers.
- Aberrant signaling, particularly activating CTNNB1 mutations, drives liver tumorigenesis.
- Understanding context-specific signaling is vital for targeted cancer therapies.
Purpose of the Study:
- To elucidate the mechanisms of tissue- and context-specific Wnt/β-catenin signaling in liver cancer.
- To identify subtype-specific transcriptional and epigenetic profiles in patient-derived tumors.
- To determine how differential β-catenin-TCF/LEF interactions influence cell fate.
Main Methods:
- Single-cell transcriptomics and chromatin dynamics profiling of patient-derived organoids.
- CUT&RUN assays to map β-catenin genomic engagement.
- Validation across multiple tumor models and patient tissues.
Main Results:
- Identified distinct transcriptional and epigenetic profiles in different liver tumor subtypes.
- β-catenin associates with specific genomic regions, influenced by TCF/LEF transcription factors.
- Defined a TCF7L2-dependent regulatory element engaged by β-catenin, dictating cell fate.
Conclusions:
- Partner choice in β-catenin-TCF/LEF interactions, not just mutation status, determines Wnt signaling outcomes.
- Provides a framework for understanding context-specific Wnt signaling in cancer.
- Offers potential therapeutic strategies targeting specific Wnt pathway interactions in liver cancer.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
